Cervantes, Phrillyn N.
HRN: 20-86-86 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/06/2023
AMPICILLIN 250MG (VIAL)
01/06/2023
01/13/2023
IVT
228mg
Q6
Pcap C
Waiting Final Action
01/21/2023
CIPROFLOXACIN 500MG (TAB)
01/21/2023
01/27/2023
ORAL
110mg
BID
Pcap
Waiting Final Action
01/21/2023
CEFTAZIDIME 1GM (VIAL)
01/21/2023
01/27/2023
IV
450mg
Q8
HAP
Waiting Final Action
01/21/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/21/2023
01/27/2023
IV
135mg
Q24
HAP
Waiting Final Action
01/21/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/21/2023
01/27/2023
IV
70mg
Q6
HAP
Waiting Final Action